EYPT:NASDAQ, EyePoint Pharmaceuticals, Inc.
EYPT stock overview
EyePoint Pharmaceuticals, Inc. (EYPT:NASDAQ) closed at $0.395 on November 4, 2026,
down 1.23% on the day.
The stock trades 97.9% below its 52-week high of $19.11
and 16.2% above its 52-week low of $0.340.
Over the past year, it lost 96.4%.
EyePoint Pharmaceuticals, Inc. is part of the Capital Goods sector (Biotechnology: Laboratory Analytical Instruments).
Key figures
- Price
- $0.395
- Day change
- -1.23%
- Volume
- 2,874,158
- Average volume
- 9,123,521
- Market cap
- 33M+
- 52-week range
- $0.340 – $19.11
- 50-day average
- $3.02
- 200-day average
- $10.83
Price action over the past year
In 252 trading sessions since November 4, 2025, EYPT closed higher on 118 days (47%).
Its best day was September 17, 2026 (+15.65%) and its worst was October 19, 2026 (-85.28%).
The stock moved 10% or more in a single session 13 times.
It opened at least 5% above the previous day's high 3 times.
Recent signals
EYPT news
-
Nov 2, 2026:
Oculis Holding AG (OCS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Oct 28, 2026:
EyePoint (EYPT) Expected to Beat Earnings Estimates: Should You Buy?
-
Oct 21, 2026:
EyePoint (EYPT) Stock Sees Fair Value Cut After Duravyu Trial Setbacks
-
Oct 20, 2026:
EyePoint halves workforce and ends Phase III trial early after endpoint miss
-
Oct 20, 2026:
Why Did EYPT, CRWV, EOSE Stocks Tumble To 52-Week Lows Today?
-
Oct 19, 2026:
EYPT Stock Layoffs: What to Know About the Latest EyePoint Job Cuts
-
Oct 19, 2026:
Top Midday Decliners
-
Oct 19, 2026:
EyePoint Drug Trial Flop Crashes Stock. Can a Strategy Shift Save It?
About EyePoint Pharmaceuticals, Inc.
pSivida Corp develops tiny, sustained-release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years.
Similar stocks
Find more stocks like EYPT with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.